Modulation of Retinal Atrophy With Rituximab in Multiple Sclerosis.
Jeffrey LambeHunter RisherAngeliki G FilippatouOlwen C MurphyElias S SotirchosHenrik EhrhardtEsther OgbuokiriNicole PellegriniBrandon ToliverNicholas J LucianoSimidele DavisNicholas FioravanteOhemaa KwakyiJerry L PrincePeter A CalabresiKathryn C FitzgeraldShiv SaidhaPublished in: Neurology (2021)
This study provides Class IV evidence on the difference in rate of change of the GCIPL thickness in patients with RRMS comparing rituximab to other disease-modifying therapies.